-- Reaffirms 2008 adjusted* earnings projection --
LAKE FOREST, Ill., Nov. 5 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a leading global specialty pharmaceutical and medication
delivery company, today reported results for the third quarter of 2008.
-- Net sales increased 10.4 percent to $925.5 million during the
third quarter of 2008, compared to $838.0 million during the
third quarter of 2007.
-- Adjusted* diluted earnings per share increased 28.6 percent in the
third quarter to $0.63 compared to $0.49 during the third quarter
last year. GAAP third-quarter 2008 diluted earnings per share were
$0.51 versus $0.37 for the same period last year. (Adjusted* measures
exclude certain specified items as described later in this press
release and attached schedules.)
"We are pleased by the strong growth we achieved during the quarter in our primary areas of strategic focus," said Christopher B. Begley, chairman and chief executive officer. "Both Specialty Injectable Pharmaceuticals and Medication Management Systems posted double-digit sales increases, and each area saw favorable developments that will drive future growth. We remain on track to achieve our 2008 earnings projections and continue to position Hospira for future success."
Third-quarter Financial Highlights
The following table summarizes selected financial results for the
quarters ended September 30:
In $ millions GAAP Adjusted*
Three Months Ended Three Months Ended
Sept. 30, Sept. 30,
---------------- % -----
|SOURCE Hospira, Inc.|
Copyright©2008 PR Newswire.
All rights reserved